238 related articles for article (PubMed ID: 32005150)
1. Identification of functional regulatory elements in the human genome using pooled CRISPR screens.
Borys SM; Younger ST
BMC Genomics; 2020 Jan; 21(1):107. PubMed ID: 32005150
[TBL] [Abstract][Full Text] [Related]
2. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
Elife; 2020 May; 9():. PubMed ID: 32441252
[TBL] [Abstract][Full Text] [Related]
3. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.
Korkmaz G; Lopes R; Ugalde AP; Nevedomskaya E; Han R; Myacheva K; Zwart W; Elkon R; Agami R
Nat Biotechnol; 2016 Feb; 34(2):192-8. PubMed ID: 26751173
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.
Klann TS; Black JB; Chellappan M; Safi A; Song L; Hilton IB; Crawford GE; Reddy TE; Gersbach CA
Nat Biotechnol; 2017 Jun; 35(6):561-568. PubMed ID: 28369033
[TBL] [Abstract][Full Text] [Related]
5. Deciphering essential cistromes using genome-wide CRISPR screens.
Fei T; Li W; Peng J; Xiao T; Chen CH; Wu A; Huang J; Zang C; Liu XS; Brown M
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25186-25195. PubMed ID: 31727847
[TBL] [Abstract][Full Text] [Related]
6. Decoding the noncoding genome via large-scale CRISPR screens.
Shukla A; Huangfu D
Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
[TBL] [Abstract][Full Text] [Related]
7. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
[TBL] [Abstract][Full Text] [Related]
8. CRISPR Screens to Discover Functional Noncoding Elements.
Wright JB; Sanjana NE
Trends Genet; 2016 Sep; 32(9):526-529. PubMed ID: 27423542
[TBL] [Abstract][Full Text] [Related]
9. High-throughput genetic screens using CRISPR-Cas9 system.
Kweon J; Kim Y
Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region.
Szafranski P; Karolak JA; Lanza D; Gajęcka M; Heaney J; Stankiewicz P
Mamm Genome; 2017 Aug; 28(7-8):275-282. PubMed ID: 28405742
[TBL] [Abstract][Full Text] [Related]
11. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
[TBL] [Abstract][Full Text] [Related]
12. Genome-scale CRISPR screening at high sensitivity with an empirically designed sgRNA library.
Henkel L; Rauscher B; Schmitt B; Winter J; Boutros M
BMC Biol; 2020 Nov; 18(1):174. PubMed ID: 33228647
[TBL] [Abstract][Full Text] [Related]
13. PICKLES: the database of pooled in-vitro CRISPR knockout library essentiality screens.
Lenoir WF; Lim TL; Hart T
Nucleic Acids Res; 2018 Jan; 46(D1):D776-D780. PubMed ID: 29077937
[TBL] [Abstract][Full Text] [Related]
14. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
[TBL] [Abstract][Full Text] [Related]
15. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
[TBL] [Abstract][Full Text] [Related]
16. Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence.
Han R; Li L; Ugalde AP; Tal A; Manber Z; Barbera EP; Chiara VD; Elkon R; Agami R
Genome Biol; 2018 Aug; 19(1):118. PubMed ID: 30119690
[TBL] [Abstract][Full Text] [Related]
17. Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in
Stolte B; Iniguez AB; Dharia NV; Robichaud AL; Conway AS; Morgan AM; Alexe G; Schauer NJ; Liu X; Bird GH; Tsherniak A; Vazquez F; Buhrlage SJ; Walensky LD; Stegmaier K
J Exp Med; 2018 Aug; 215(8):2137-2155. PubMed ID: 30045945
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
19. p53 regulates enhancer accessibility and activity in response to DNA damage.
Younger ST; Rinn JL
Nucleic Acids Res; 2017 Sep; 45(17):9889-9900. PubMed ID: 28973438
[TBL] [Abstract][Full Text] [Related]
20. Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression.
Rosenbluh J; Xu H; Harrington W; Gill S; Wang X; Vazquez F; Root DE; Tsherniak A; Hahn WC
Nat Commun; 2017 May; 8():15403. PubMed ID: 28534478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
